C-289 — Stopping Supply to Save Lives Act
Bill C-289 · Legislation · 10/28/2026, 5:19:11 PM
Bill summary
Based on the official bill text (First reading, June 17, 2026) — Parliament of Canada (LEGISinfo/DocumentViewer)
Status
- Bill C-289 received first reading on June 17, 2026. It would amend the Controlled Drugs and Substances Act and the Criminal Code.
Controlled Drugs and Substances Act
- For offences involving trafficking or possession for the purpose of trafficking a synthetic opioid in Schedule I:
- More than 40 mg: mandatory life imprisonment.
- 20 mg to 40 mg: a minimum of 15 years’ imprisonment, with a maximum of life.
- For import, export or production offences involving more than 40 mg of a Schedule I synthetic opioid, the bill would impose mandatory life imprisonment.
- Other Schedule I or II substances remain subject to a maximum sentence of life imprisonment under the provisions amended by the bill.
- When sentencing a person for a designated substance offence involving a Schedule I synthetic opioid, a court would have to consider as aggravating factors:
- The offence being committed within 300 metres of a substance use treatment centre, school, child care facility or another location protecting vulnerable persons that is designated by regulation.
- An amount of at least 2 mg for a substance listed in item 16 of Schedule I; or, for any other such substance, an amount reasonably expected to cause death if consumed.
- The bill would add a regulation-making power to designate additional locations for the proximity factor.
Criminal Code
- People convicted of the specified trafficking, possession-for-trafficking, import, export or production offences involving more than 40 mg of a Schedule I synthetic opioid would be sentenced to life imprisonment without eligibility for parole until they had served 25 years.
Costs and timing
- The provided text does not specify costs or a coming-into-force date.
Discourse summary
A civic summary of this discussion will appear here once there are comments.
Discussion 0 comments
Sign in or create an account to comment and vote.
No comments yet. Start the discussion.